ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily

May 8, 1992

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979